trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Captopril and ramiprilate act as angiotensin converting enzyme inhibitors.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Captopril and ramiprilate act as angiotensin converting enzyme inhibitors?

Yes. Captopril and ramiprilat are well-documented pharmacological agents that function as angiotensin-converting enzyme (ACE) inhibitors to block the renin-angiotensin system.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently confirms that captopril and ramiprilat function as angiotensin-converting enzyme (ACE) inhibitors, as demonstrated by their pharmacological classification and specific binding studies to ACE.

Evidence for · 3
A Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension.
2019
Identifies angiotensin-converting enzyme (ACE) inhibitors as key therapeutic agents targeting the conversion of angiotensin I to angiotensin II.
Get citation
SA, A., M, H., M, U., RM, A., S, M., KA, A., M, B., & MZ, N. (2019). A Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension.. doi.org. https://doi.org/10.3390/ijerph16060923

See more details
More for · 2
Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective.
2022
Explains that ACE inhibitors (ACEIs) decrease the formation of angiotensin II by inhibiting the central zinc metalloprotein ACE.
Get citation
W, Z., E, T., Z, L., C, Z., P, Y., K, T., W, L., J, L., & C, R. (2022). Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective.. doi.org. https://doi.org/10.3389/fphar.2022.968104

Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.
1992
Utilizes radioligand binding with the ACE inhibitor [3H]-ramiprilat to identify and characterize ACE binding sites in human tissues.
Get citation
T, V., M, B., F, C., G, B., E, O., E, C., A, M., & G, N. (1992). Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.. doi.org. https://doi.org/10.1111/j.1476-5381.1992.tb14530.x

What does the evidence say?

The retrieved literature consistently confirms that captopril and ramiprilat function as angiotensin-converting enzyme (ACE) inhibitors, as demonstrated by their pharmacological classification and specific binding studies to ACE.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work